Ligand Pharmaceuticals Inc (NASDAQ:LGND)

Delayed Data
As of May 18
 +3.85 / +2.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 176.00, with a high estimate of 200.00 and a low estimate of 119.00. The median estimate represents a -9.74% decrease from the last price of 194.99.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -35.35%
Growthannually 56.81%


Growthquarterly -28.89%
Growthannually 35.23%
Key to the earnings and sales forecast charts.